Evidence map›Paper›PMID 30145707›Full record

Observational studyAIDS and behavior2019

Prevalence and Correlates of Unhealthy Alcohol and Drug Use Among Men Who Have Sex with Men Prescribed HIV Pre-exposure Prophylaxis in Real-World Clinical Settings.

Onyema Ogbuagu, Brandon D L Marshall, Perry Tiberio, Adedotun Ogunbajo, Lydia Barakat, Madeline Montgomery, Alexi Almonte, Tyler Wray, Emily C Williams, E Jennifer Edelman and 1 more

Abstract readObservational Study
In one paragraph

Observational study in AIDS and behavior, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Retrospective audit of a convenience cohort of individuals on HIV pre-exposure prophylaxis in Alberta, Canada.Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Onyema OgbuaguYale AIDS Program, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA. Onyema.ogbuagu@yale.edu.ORCID http://orcid.org/0000-0001-7342-2608
Brandon D L MarshallDepartment of Epidemiology, Brown University School of Public Health, Providence, RI, USA.
Perry TiberioDepartment of Medicine, Yale-New Haven Hospital, New Haven, CT, USA.
Adedotun OgunbajoDepartment of Epidemiology, Brown University School of Public Health, Providence, RI, USA.
Lydia BarakatYale AIDS Program, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA.
Madeline MontgomeryDepartment of Medicine, Brown University, Providence, RI, USA.
Alexi AlmonteDepartment of Medicine, Brown University, Providence, RI, USA.
Tyler WrayDepartment of Behavioral and Social Sciences, Brown University School of Public Health, Providence, RI, USA.
Emily C WilliamsDepartment of Health Services, University of Washington School of Public Health, Seattle, WA, USA.
E Jennifer EdelmanSection of General Internal Medicine, Department of Medicine, Yale School of Medicine, New Haven, CT, USA.
Philip A ChanDepartment of Medicine, Brown University, Providence, RI, USA.

Funding

Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI LARRY K BROWN · 1998 to 2026
$51.7M
Using Coincidence Analysis to Investigate Factors Affecting PrEP Initiation and Continuation in Southern ending the Epidemic CountiesP30MH062294 · NIMH · YALE UNIVERSITY · PI John Edward Pachankis · 2001 to 2026
$48.5M
Yale Drug use, Addiction and HIV Research Scholars (DAHRS)K12DA033312 · NIDA · YALE UNIVERSITY · PI Gail D'Onofrio, Patrick O'Connor · 2013 to 2026
$7.2M
Minority Populations Prevention Researcher TrainingR25HD045810 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI NEILANDS, TORSTEN BRIAN · 2003 to 2018
$4.3M
The Brown Initiative in HIV and AIDS Clinical Research for Minority CommunitiesR25MH083620 · NIMH · MIRIAM HOSPITAL · PI NUNN, AMY STEWART · 2008 to 2025
$3.7M
Characterizing the HIV pre-exposure prophylaxis care continuum for African American and Hispanic/Latino men who have sex with menR01MH114657 · NIMH · MIRIAM HOSPITAL · PI CHAN, PHILIP ANDREW, NUNN, AMY STEWART · 2017 to 2021
$3.4M
Optimizing PrEP uptake & Adherence among MSWs using a 2-stage randomization designR34MH110369 · NIMH · BROWN UNIVERSITY · PI BIELLO, KATIE BROOKS, CHAN, PHILIP ANDREW · 2016 to 2018
$879k
PrEP uptake, adherence & retention for African American MSM in MississippiR34MH109371 · NIMH · BROWN UNIVERSITY · PI CHAN, PHILIP ANDREW, MENA, LEANDRO ANTONIO · 2016 to 2018
$736k
A brief motivational interviewing-based intervention to improve HIV pre-exposure prophylaxis uptake among men who have sex with menR34DA042648 · NIDA · MIRIAM HOSPITAL · PI CHAN, PHILIP ANDREW, MOITRA, ETHAN · 2017 to 2019
$692k
Enhancing Population Impact of HIV Pre-Exposure Prophylaxis ImplementationR21MH109360 · NIMH · BROWN UNIVERSITY · PI CHAN, PHILIP ANDREW, MARSHALL, BRANDON DAVID LEWIS · 2016 to 2017
$459k
Evaluating HIV pre-exposure prophylaxis implementation using an all payers claims databaseR21MH113431 · NIMH · MIRIAM HOSPITAL · PI CHAN, PHILIP ANDREW, GALARRAGA, OMAR · 2017 to 2018
$426k
Lifespan/Tufts/Brown Center for AIDS Research P30AI042853National Institutes of Health (US) K12DA033312NIAID NIH HHS P30 AI042853NICHD NIH HHS R25 HD045810NIDA NIH HHS K12 DA033312NIDA NIH HHS R34 DA042648NIH HHS R21MH109360NIH HHS R21MH113431NIH HHS R34DA042648NIH HHS R34MH109371NIH HHS R34MH110369NIMH NIH HHS P30 MH062294NIMH NIH HHS R01 MH114657NIMH NIH HHS R21 MH109360NIMH NIH HHS R21 MH113431NIMH NIH HHS R25 MH083620NIMH NIH HHS R34 MH109371NIMH NIH HHS R34 MH110369Yale Center for Interdisciplinary research on AIDS 5P30MH62294
6 · The paper itself

Abstract

Pre-exposure prophylaxis (PrEP) is effective in preventing HIV acquisition among men who have sex with men (MSM). However, little is known about unhealthy substance use among MSM initiating PrEP in real-world settings. Unhealthy substance use is a risk factor for HIV acquisition and non-adherence to treatment, and may also impact PrEP use. MSM who were prescribed PrEP from 2015 to 2017 at clinics in Providence, Rhode Island and New Haven, Connecticut were recruited to participate in a prospective observational study. Structured clinical assessments were used to assess demographics, HIV risk behaviors, and unhealthy alcohol (alcohol use disorders identification test [AUDIT]-C scores ≥ 4) and drug use (use of any drugs in the past 3 months). Bivariate and multivariate analyses were performed to determine demographics and behaviors associated with unhealthy alcohol and drug use. Among 172 MSM initiating PrEP, 64% were white and 40% were 25-34 years old. Participants reported a median of 3 (IQR 2-7) sexual partners in the last 3 months; 20% reported an HIV positive partner. Unhealthy alcohol and any drug use were reported by 54 and 57%, respectively, and 76% reported at least one of the two. The majority of drug use reported was marijuana and poppers (41 and 26% of participants, respectively). Relative to those without unhealthy alcohol use, unhealthy alcohol use was independently associated with any drug use (adjusted odds ratio [AOR] = 2.57, 95% CI 1.32-5.01). Frequent drug use was associated with younger age (< 25 years, AOR 4.27, 95% CI 1.51-12.09). Unhealthy alcohol use is common among MSM taking PrEP. Drug use other than marijuana and poppers was uncommon among our cohort. Further efforts may be needed to understand the influence of unhealthy alcohol and other substance use on PrEP outcomes and to engage MSM who use drugs for PrEP.

Indexed as

Pre-Exposure ProphylaxisSexual and Gender MinoritiesAdultAlcoholismAnti-HIV AgentsConnecticutHIVHIV InfectionsHomosexuality, MaleHumansMaleMarijuana UseMiddle AgedOdds RatioPrevalenceProspective StudiesAnti-HIV AgentsAlcoholHIVImplementationMen who have sex with menPre-exposure prophylaxis

Identifiers

PMID30145707
PMCPMC7020905

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.